Thomas Matthes Joins Sloning BioTechnology GmbH as Chief Business Officer to Drive Global Sales and Marketing Activities for Sloning BioTechnology GmbH’s Gene Synthesis Service (Slonomics(TM)) and Custom Mutant Libraries (SlonoMax(TM))

PUCHHEIM, Germany--(BUSINESS WIRE)--Sloning Biotechnology, the innovator and technological leader in the emerging gene synthesis market, has appointed Thomas Matthes as Chief Business Officer to further strengthen Sloning’s sales and marketing activities in Europe, North America and Asia.